DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kato K, Cho BC, Takahashi M. et al.
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol 2019;
20 (11) 1506-1517
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.